ArticleJournal of nanobiotechnology2025
Correction: Co-delivery of axitinib and PD-L1 siRNA for the synergism of vascular normalization and immune checkpoint Inhibition to boost anticancer immunity.
Yanhong Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.